This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: D. Western Therapeutics Institute, Inc.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: **Innovator Spotlight: Takashi Izuhara of Nagoya, Japan**
Introduction
Takashi Izuhara is a distinguished inventor based in Nagoya, Japan. He is known for his contributions to the pharmaceutical field, and his innovative spirit has led to the development of a patent that showcases his expertise and dedication to research.
Latest Patents
Takashi holds a patent for a substance titled "Form of isoquinoline sulfonamide." This patent pertains to a stable crystal of a salt of N—[(R)-1-{(S)-2-hydroxy-2-phenylpropylamino}propan-2-yl]isoquinoline-6-sulfonamide. This compound may have desirable properties as a pharmaceutical drug substance, especially the N—[(R)-1-{(S)-2-hydroxy-2-phenylpropylamino}propan-2-yl]isoquinoline-6-sulfonamide dihydrochloride anhydride. The crystal of the anhydride is noted for its characteristic peaks in the powder X-ray diffraction spectrum at specific angles.
Career Highlights
Takashi is currently associated with the D. Western Therapeutics Institute, Inc., where he applies his deep understanding of chemistry and drug development in his work. His single patent reflects his ability to create valuable innovations in the complex world of pharmaceuticals.
Collaborations
Throughout his career, Takashi has collaborated with prominent figures in his field, including Hiroyoshi Hidaka and Kengo Sumi. These partnerships have likely enriched his research and contributed to his success as an inventor.
Conclusion
In conclusion, Takashi Izuhara exemplifies the dedication and creativity of modern inventors in the pharmaceutical industry. His innovative work on isoquinoline sulfonamide sets a precedent for future advancements in drug substances, making him a vital contributor to the field. His journey serves as an inspiration for aspiring inventors and researchers worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile